[1] D. Neupane, A. Rijal, M.E. Henry, P. Kallestrup, B. Koirala, C.S. McLachlan, K. Ghimire, D. Zhao, S. Sharma, Y. Pokharel, K. Joseph, M.H. Olsen, A.E. Schutte, L.J. Appel, Mean dietary salt intake in Nepal: A population survey with 24-hour urine collections, J Clin Hypertens (Greenwich), 22 (2020) 273-279.
[2] D. Malta, K.S. Petersen, C. Johnson, K. Trieu, S. Rae, K. Jefferson, J.A. Santos, M.M.Y. Wong, T.S. Raj, J. Webster, N.R.C. Campbell, J. Arcand, High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017), J Clin Hypertens (Greenwich), 20 (2018) 1654-1665.
[3] Y. Xue, Q. Wen, C. Xu, X. Zhang, J. Zeng, A.M. Sha, C. Lan, L. Li, H. Wang, X. Yang, C. Zeng, Elevated Salt Taste Threshold Is Associated with Increased Risk of Coronary Heart Disease, J Cardiovasc Transl Res, (2020).
[4] Y. Patel, J. Joseph, Sodium Intake and Heart Failure, Int J Mol Sci, 21 (2020).
[5] D. Susic, E.D. Frohlich, Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects, Curr Opin Lipidol, 23 (2012) 11-16.
[6] A.C. Gomes, I. Falcao-Pires, A.L. Pires, C. Bras-Silva, A.F. Leite-Moreira, Rodent models of heart failure: an updated review, Heart Fail Rev, 18 (2013) 219-249.
[7] T.R. Eijgenraam, H.H.W. Sillje, R.A. de Boer, Current understanding of fibrosis in genetic cardiomyopathies, Trends Cardiovasc Med, 30 (2020) 353-361.
[8] C.M. Shea, G.M. Price, G. Liu, R. Sarno, E.S. Buys, M.G. Currie, J.L. Masferrer, Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure, Am J Physiol Renal Physiol, 318 (2020) F148-F159.
[9] Y. Hayakawa, T. Aoyama, C. Yokoyama, C. Okamoto, H. Komaki, S. Minatoguchi, M. Iwasa, Y. Yamada, I. Kawamura, M. Kawasaki, K. Nishigaki, A. Mikami, F. Suzuki, S. Minatoguchi, High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension, PLoS One, 10 (2015) e0120453.
[10] O. Dumont, F. Pinaud, A.L. Guihot, C. Baufreton, L. Loufrani, D. Henrion, Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine, Cardiovasc Res, 77 (2008) 600-608.
[11] R. Agocs, D. Sugar, A.J. Szabo, Is too much salt harmful? Yes, Pediatr Nephrol, 35 (2020) 1777-1785.
[12] D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116 (2004) 281-297.
[13] M. Javadian, T. Gharibi, N. Shekari, M. Abdollahpour-Alitappeh, A. Mohammadi, A. Hossieni, H. Mohammadi, T. Kazemi, The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis, J Cell Physiol, (2018).
[14] E. van Rooij, The art of microRNA research, Circ Res, 108 (2011) 219-234.
[15] A.M. Mohr, J.L. Mott, Overview of microRNA biology, Semin Liver Dis, 35 (2015) 3-11.
[16] J.N. Jones Buie, A.J. Goodwin, J.A. Cook, P.V. Halushka, H. Fan, The role of miRNAs in cardiovascular disease risk factors, Atherosclerosis, 254 (2016) 271-281.
[17] Y. Guan, X. Song, W. Sun, Y. Wang, B. Liu, Effect of Hypoxia-Induced MicroRNA-210 Expression on Cardiovascular Disease and the Underlying Mechanism, Oxid Med Cell Longev, 2019 (2019) 4727283.
[18] C. Liu, C.X. Yang, X.R. Chen, B.X. Liu, Y. Li, X.Z. Wang, W. Sun, P. Li, X.Q. Kong, Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats, Amino Acids, 50 (2018) 1071-1081.
[19] O.V. Fedorova, M.I. Talan, N.I. Agalakova, E.G. Lakatta, A.Y. Bagrov, Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension, J Hypertens, 22 (2004) 389-397.
[20] F. Nista, F. Gatto, M. Albertelli, N. Musso, Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain, Int J Environ Res Public Health, 17 (2020).
[21] Y. Takeda, T. Yoneda, M. Demura, I. Miyamori, H. Mabuchi, Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy, Endocrinology, 141 (2000) 1901-1904.
[22] M. Liu, M. Deng, Q. Luo, X. Dou, Z. Jia, High-Salt Loading Downregulates Nrf2 Expression in a Sodium-Dependent Manner in Renal Collecting Duct Cells, Front Physiol, 10 (2019) 1565.
[23] D. Zhang, C. Wang, S. Cao, Z. Ye, B. Deng, A. Kijlstra, P. Yang, High-Salt Enhances the Inflammatory Response by Retina Pigment Epithelium Cells following Lipopolysaccharide Stimulation, Mediators Inflamm, 2015 (2015) 197521.
[24] G. Sygitowicz, A. Maciejak-Jastrzebska, D. Sitkiewicz, MicroRNAs in the development of left ventricular remodeling and postmyocardial infarction heart failure, Pol Arch Intern Med, 130 (2020) 59-65.
[25] L. Medzikovic, L. Aryan, M. Eghbali, Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis, J Mol Med (Berl), 97 (2019) 1385-1398.
[26] M. Dutka, R. Bobinski, J. Korbecki, The relevance of microRNA in post-infarction left ventricular remodelling and heart failure, Heart Fail Rev, 24 (2019) 575-586.
[27] G. Condorelli, M.V. Latronico, G.W. Dorn, 2nd, microRNAs in heart disease: putative novel therapeutic targets?, Eur Heart J, 31 (2010) 649-658.
[28] R. Dumache, V. Ciocan, C. Muresan, A.F. Rogobete, A. Enache, Circulating MicroRNAs as Promising Biomarkers in Forensic Body Fluids Identification, Clin Lab, 61 (2015) 1129-1135.
[29] H.A. Cakmak, M. Demir, MicroRNA and Cardiovascular Diseases, Balkan Med J, 37 (2020) 60-71.
[30] J. Wang, Y. Zhang, Y.M. Liu, L.L. Guo, P. Wu, Y. Dong, G.J. Wu, Huoxue Anxin Recipe () promotes myocardium angiogenesis of acute myocardial infarction rats by up-regulating miR-210 and vascular endothelial growth factor, Chin J Integr Med, 22 (2016) 685-690.
[31] W.S. Bian, P.X. Shi, X.F. Mi, Y.Y. Sun, D.D. Yang, B.F. Gao, S.X. Wu, G.C. Fan, MiR-210 protects cardiomyocytes from OGD/R injury by inhibiting E2F3, Eur Rev Med Pharmacol Sci, 22 (2018) 743-749.
[32] N.G. Frangogiannis, Cardiac fibrosis, Cardiovasc Res, (2020).
[33] K. Tzavlaki, A. Moustakas, TGF-beta Signaling, Biomolecules, 10 (2020).
[34] J. Liu, F. Liu, The Yin and Yang function of microRNAs in insulin signalling and cancer, RNA Biol, 18 (2021) 24-32.
[35] S. Paul, L.M. Ruiz-Manriquez, S.J. Ledesma-Pacheco, J.A. Benavides-Aguilar, A. Torres-Copado, J.I. Morales-Rodriguez, M. De Donato, A. Srivastava, Roles of microRNAs in chronic pediatric diseases and their use as potential biomarkers: A review, Arch Biochem Biophys, 699 (2021) 108763.